Key stats
Market capitalization
220.105MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.28USD
About Savara, Inc
ISIN
US8051111016
Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
savarapharma.com
CEO
Matthew Pauls
Headquarters
Austin
Employees
22
Founded
1995
Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. The firm's lead program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF, is being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Austin, TX.
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0